CDI Labs
Barney Saunders is a CEO with a background in founding and leading companies in the life sciences and diagnostics industry. Currently serving as the CEO of CDI Labs, a company focused on immune biomarker discovery platforms. Prior to this, Barney founded Saunders Bioconsulting and served as the CEO of Purigen Biosystems. With experience at companies like NanoString Technologies, Microchip Biotechnologies, Agilent Technologies, and Amersham Biosciences. Barney Saunders holds a B.Sc and Ph.D in Biological Sciences from the University of Birmingham.
CDI Labs
The Seromics Company - We believe that future discoveries depend on a deeper understanding of individual proteins. We’ve combined our vast proteomic libraries with a deep expertise in synthetic biology to create an extensive collection of products and services serving the following areas of science. Our industry-leading HuProt™ array consists of >21,000 unique human proteins, isoform variants, and protein fragments that cover 16,794 unique genes. • Human autoantibody seromics discovery • Protein-protein interactions • Target ID of unknown binders • Antibody specificity Now introducing PhIP-Seq – with MouseScan™ and HuScan™ phage display libraries. At CDI Labs, we believe that partnering with both companies and academic scientists is the path to mutual success. Join us in creating the antigen-specific revolution, and help unravel some of the greatest mysteries in human health.